These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 18704409)

  • 1. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
    van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
    Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Approaches for Immune Directed Treatment for Ovarian Cancer.
    Hardwick N; Frankel PH; Cristea M
    Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
    Zhang T; Herlyn D
    Cancer Immunol Immunother; 2009 Apr; 58(4):475-92. PubMed ID: 18925393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
    Apetoh L; Ladoire S; Coukos G; Ghiringhelli F
    Ann Oncol; 2015 Sep; 26(9):1813-1823. PubMed ID: 25922066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells.
    Bodey B
    Expert Opin Biol Ther; 2001 Jul; 1(4):603-17. PubMed ID: 11727497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole cell vaccines--past progress and future strategies.
    Keenan BP; Jaffee EM
    Semin Oncol; 2012 Jun; 39(3):276-86. PubMed ID: 22595050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].
    Alfaro C; Murillo O; Tirapu I; Azpilicueta A; Huarte E; Arina A; Arribillaga L; Pérez-Gracia JL; Bendandi M; Prieto J; Lasarte JJ; Melero I
    An Sist Sanit Navar; 2006; 29(1):77-96. PubMed ID: 16670731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination immunotherapy approaches.
    Drake CG
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii41-6. PubMed ID: 22918927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects.
    Kothari N; Postwala H; Pandya A; Shah A; Shah Y; Chorawala MR
    Med Oncol; 2023 Apr; 40(5):135. PubMed ID: 37014489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations.
    Parchment RE; Voth AR; Doroshow JH; Berzofsky JA
    Semin Oncol; 2016 Aug; 43(4):501-13. PubMed ID: 27663482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine therapies for non-Hodgkin's lymphoma.
    Timmerman JM
    Curr Treat Options Oncol; 2002 Aug; 3(4):307-15. PubMed ID: 12074767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer immunotherapy: recent breakthroughs and perspectives].
    Tartour E; Sandoval F; Bonnefoy JY; Fridman WH
    Med Sci (Paris); 2011 Oct; 27(10):833-41. PubMed ID: 22027420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination strategies to enhance antitumor ADCC.
    Kohrt HE; Houot R; Marabelle A; Cho HJ; Osman K; Goldstein M; Levy R; Brody J
    Immunotherapy; 2012 May; 4(5):511-27. PubMed ID: 22642334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.